Skip to main content

Multiple Sclerosis (MS) Drugs & Exposure before, during, and after Pregnancy

Basic Details
Status
Complete
Last Updated
Thursday, December 6, 2018
Health Outcome(s)
exposure before, during, and after pregnancy
Purpose
Drug Use
Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
No
Regulatory Determination / Use

Contextualized enrollment and recruitment in MS pregnancy registries. Described patterns of drug use before, during, and after pregnancy.

Result(s) (2)
Use of Multiple Sclerosis Drugs Among Pregnant Women Use of Multiple Sclerosis Drugs Among Pregnant Women with Live-Birth Deliveries: A Descriptive Analysis
Related Publication(s) and/or Presentation(s) (1)
Presentation: Use of Multiple Sclerosis Drugs Among Live Birth Pregnancies in the United States